NK cells briefly pre-activated by this combination of cytokines (IL-12, IL-15 and IL-18) were previously shown to have a sustained effector function in tumour mouse models and an enhanced proliferative capacity as well as an increased IFN-γ response over time in human in vitro studies [46, 47]. This evidence concerns the gene IFNG and neoplasm.